| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1295bdd926a383ce586b8bfbfb1bdbb1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-215 |
| filingDate |
2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e9587a7451c770d0276ce49987abdf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4be22e6fec9f453e1dbb372aff5b935 |
| publicationDate |
2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112898437-A |
| titleOfInvention |
A kind of novel coronavirus antigen and its preparation method and application |
| abstract |
A novel coronavirus antigen, preparation method and application thereof, the novel coronavirus antigen comprises a fusion protein, the fusion protein comprises a Spike protein S1 domain part and an HSA part, wherein the Spike protein S1 domain part corresponds to the Spike protein Arginine at position 685 was replaced with glycine. The fusion protein prepared by the present invention is used as the key antigen component in the new coronavirus serum antibody detection kit for the detection of the new coronavirus antibody; as a vaccine, it is given to animals or humans to generate antibodies for the prevention of the new coronavirus. It is given to new crown patients as a therapeutic drug to treat new coronavirus pneumonia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478716-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023051850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113943375-A |
| priorityDate |
2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |